Rezultati pretraživanja
  1. 31. sij

    Very excited about this commercialization project; integrating biomarker-based business model with and service delivery platform!

  2. 30. sij

    New! Lo & colleagues delineate the process of cell-free DNA fragmentation

  3. 30. sij

    Swift Accel NGS® 2S Library Kits Higher library complexity for ultra low-input DNA and damaged DNA samples The best prep for ChiP, Hi-C, FFPE, cell-free DNA, and low input metagenomes

  4. 29. sij

    Making libraries from a bit challenging & low input samples like cfDNA or FFPE? Check the advantages of 2S chemistry

  5. 29. sij
    Odgovor korisnicima i sljedećem broju korisnika:

    Congrats for great study on diversity and impact on response monitoring

  6. Cutting-edge session on today at 2:10 pm with Dr. Christopher Smith at the main stage!

  7. 28. sij

    Identifying responders remains a key challenge in . Our paper in explores the impact of filtering out the signal from leukocytes in to better predict recurrence in .

  8. 26. sij

    Must use caution (and still use tissue!) as the number of markers expand .... but NILE did show 💯 % PPV for egfr, alk, ros1, and braf

    Prikaži ovu nit
  9. 11. sij
  10. Very interesting and well-written review on cfDNA in cancer and placenta

  11. 8. pro 2019.

    This is 100% the craziest poster at - if true (a big if!) this is some bizarre and fascinating biology.

  12. 6. pro 2019.

    re cell free (cf) and circulating tumour (ct) DNA. Lesson 1: not the same thing! - cfDNA - all DNA not in cells. Found in healthy controls, often from cell turnover during haematopoiesis - ctDNA - derived from tumour so should not be there in controls

    Prikaži ovu nit
  13. 26. stu 2019.

    New work from Reis-Filho and ⁦⁩ in ⁦⁩ reporting a comprehensive analysis revealing as major source of somatic mutations in plasma. ⁦

  14. 12. stu 2019.

    Our review of technological considerations, pre-analytical variables and reference materials for , , and in liquid biopsy testing is now published in Molecular Aspects of Medicine :

  15. 5. stu 2019.

    Here come our assay!! Measure TMB, MSI, CNV and SNV in blood samples with TruSight Oncology 500 ctDNA. Runs on a .

  16. 3. stu 2019.

    Fiesty panel debating the merits and pitfalls of to close last week. was predicted to beat ... just like was supposed to thrash ... and the winner was... !

  17. 30. ruj 2019.

    It was an honor to be selected by , a pioneer and thought leader in this field. . Great collaboration with

  18. 18. ruj 2019.

    applications of -free in management. 📚 The emerging role of cell-free DNA as a molecular marker for cancer management

  19. 26. kol 2019.

    Ever wonder if there was a simple, yet reliable way to differentiate from ? My brilliant brother used signatures to differentiate replication from disease after

  20. 5. kol 2019.

    Welcome new literature bots (based on PubMed, bioRxiv, medRxiv): 📌 – cell free DNA (); 📌 – cancer epigenetics; This is in addition to the existing bots: , , ,

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.